Innovation in the pharma industry (part 4): how do you see delivery of innovation changing for pharma in the future?

pharmaphorum

In association with Cegedim Relationship Management

pharmaphorum spoke with a number of attendees of the Cegedim Relationship Management’s ‘2012 Life Science Forum’ on their views on how the delivery of innovation will change for pharma in the future. Their responses can be seen in this video in the final part of this four-part video series.

(Continued from ‘Innovation in the pharma industry (part 3): what can help pharma to drive innovation? ’)

Previously in this series, we have looked at how well pharma is currently driving innovation, what challenges there are to implementing it and what can help pharma to drive innovation.

In this final part we asked attendees of Cegedim Relationship Management’s ‘2012 Life Science Forum’ ‘how do you see delivery of innovation changing for pharma in the future?’ Their responses can be viewed in the video below.

This is the fourth of a four-part video series looking at innovation within pharma. Links to the other videos can be seen below.

Watch the short video review below to find out who we spoke with and what they shared.

&nbsp,

Subscribe to pharmaphorum on YouTube to be the first to hear about new videos – http://www.youtube.com/pharmaphorum.

Other videos in this series on innovation in the pharma industry can be viewed at the following links:-

Part 1: how well is pharma driving innovation?

Part 2: what challenges are there to implementing innovation?

Part 3: what can help pharma to drive innovation?

The full video can be viewed on YouTube here.

&nbsp,

Cegedim-Relationship-Management-IAB

&nbsp,

About Cegedim Relationship Management:

With a presence in more than 80 countries, Cegedim Relationship Management combines its global expertise with a deep understanding of local markets to help clients promote and market their products in the most efficient and cost-effective manner.

How do you see delivery of innovation changing for pharma in the future?